Related Articles
Characterization of cytomegalovirus pp65-HLA-A24 peptide-specific CTL lines from metastatic melanoma patients
Dendritic cell-based vaccination in metastatic melanoma patients: Phase II clinical trial
Variable expression on lung cancer cell lines of HLA-A2-binding MAGE-3 peptide recognized by cytotoxic T lymphocytes.
A peptide antigen derived from EGFR T790M is immunogenic in non‑small cell lung cancer
Identification of a novel HLA-A*02:01-restricted cytotoxic T lymphocyte epitope derived from the EML4-ALK fusion gene